Immunology Service of Infectious Diseases (ISID), Federal University of Bahia, Salvador, Bahia, Brazil,
Mycopathologia. 2013 Oct;176(3-4):295-7. doi: 10.1007/s11046-013-9670-z. Epub 2013 Aug 13.
Galactomannan (GM) was recently included in consensus guidelines as an indirect mycological criterion for the diagnosis of invasive aspergillosis. Currently, there is an enzyme immunoassay available to detect GM in biological samples, the Platelia™ Aspergillus EIA. In this study, the reproducibility of positive results obtained using this assay was evaluated using serum samples from neutropenic patients. A trend toward lower values was observed, and 55 %(27/49) of positive results were negative after retesting. A low reproducibility of positive results for the detection of GM in serum was observed.
半乳甘露聚糖(GM)最近被纳入共识指南,作为侵袭性曲霉病诊断的间接真菌学标准。目前,有一种酶免疫测定法可用于检测生物样本中的 GM,即 Platelia™ Aspergillus EIA。在这项研究中,使用中性粒细胞减少症患者的血清样本评估了该检测方法阳性结果的重现性。观察到结果值呈下降趋势,并且重新检测后 55%(27/49)的阳性结果为阴性。在血清中检测 GM 时,阳性结果的重现性较低。